- KBP BioSciences Signs Memorandum of Understanding with BullFrog AI
- Positive FDA Type B Meeting on KBP-5074
- KBP-7072 obtained QIDP and Fast Track Designations
- Presenting the annual meeting of the American Society of Nephrology (ASN)
- Presenting the 2016 China BioMed Innovation and Investment Conference
- Promotion of Dr. Fred Yang to Chief Development Officer
Read All